Two novel JAK2 exon 12 mutations in JAK2V617F-negative polycythaemia vera patients

被引：57

作者：

Butcher, C. M. ^{[1
]}

Hahn, U. ^{[2
]}

To, L. B. ^{[3
]}

Gecz, J. ^{[4
]}

Wilkins, E. J. ^{[5
]}

Scott, H. S. ^{[5
]}

Bardy, P. G. ^{[2
]}

D'Andrea, R. J. ^{[1
,2
,6
,7
]}

机构：

[1] Child Hlth Res Inst, Haematol & Oncol Program, Adelaide, SA, Australia

[2] Queen Elizabeth Hosp, Dept Haematol & Oncol, Woodville, SA 5011, Australia

[3] Inst Med & Vet Sci, Div Haematol, Adelaide, SA 5000, Australia

[4] Univ Adelaide, Dept Med Genet, Adelaide, SA, Australia

[5] Walter & Eliza Hall Inst Med Res, Div Mol Med, Parkville, Vic, Australia

[6] Univ Adelaide, Discipline Paediat, Adelaide, SA, Australia

[7] Univ Adelaide, Discipline Genet, Adelaide, SA, Australia

来源：

LEUKEMIA | 2008年 / 22卷 / 04期

关键词：

D O I：

10.1038/sj.leu.2404971

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：870 / 873

页数：5

共 8 条

[1] Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders [J].

Baxter, EJ ;

Scott, LM ;

Campbell, PJ ;

East, C ;

Fourouclas, N ;

Swanton, S ;

Vassiliou, GS ;

Bench, AJ ;

Boyd, EM ;

Curtin, N ;

Scott, MA ;

Erber, WN ;

Green, AR .

LANCET, 2005, 365 (9464) :1054-1061

[2] The JAK2 V617F mutation occurs in hematopoietic stem cells in polycythemia vera and predisposes toward erythroid differentiation [J].

Jamieson, CHM ;

Gotlib, J ;

Durocher, JA ;

Chao, MP ;

Mariappan, MR ;

Lay, M ;

Jones, C ;

Zehnder, JL ;

Lilleberg, SL ;

Weissman, IL .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2006, 103 (16) :6224-6229

[3] The chronic myeloproliferative disorders and mutation of JAK2: Dameshek's 54 year old speculation comes of age [J].

Kaushansky, Kenneth .

BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2007, 20 (01) :5-12

[4] The JAK2 V617F mutation involves B- and T-lymphocyte lineages in a subgroup of patients with Philadelphia-chromosome negative chronic myeloproliferative disorders [J].

Larsen, Thomas Stauffer ;

Christensen, Jacob Haaber ;

Hasselbalch, Hans Carl ;

Pallisgaard, Niels .

BRITISH JOURNAL OF HAEMATOLOGY, 2007, 136 (05) :745-751

[5]

PARDANANI A, 2007, LEUKEMIA 0628, P1

[6] MPL515 mutations in myeloproliferative and other myeloid disorders:: a study of 1182 patients [J].

Pardanani, Animesh D. ;

Levine, Ross L. ;

Lasho, Terra ;

Pikman, Yana ;

Mesa, Ruben A. ;

Wadleigh, Martha ;

Steensma, David P. ;

Elliott, Michelle A. ;

Wolanskyj, Alexandra R. ;

Hogan, William J. ;

McClure, Rebecca F. ;

Litzow, Mark R. ;

Gilliland, D. Gary ;

Tefferi, Ayalew .

BLOOD, 2006, 108 (10) :3472-3476

[7] JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis [J].

Scott, Linda M. ;

Tong, Wei ;

Levine, Ross L. ;

Scott, Mike A. ;

Beer, Philip A. ;

Stratton, Michael R. ;

Futreal, P. Andrew ;

Erber, Wendy N. ;

McMullin, Mary Frances ;

Harrison, Claire N. ;

Warren, Alan J. ;

Gilliland, D. Gary ;

Lodish, Harvey F. ;

Green, Anthony R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2007, 356 (05) :459-468

[8] Proposals and rationale for revision of the World Health Organization diagnostic criteria for polycythemia vera, essential thrombocythemia, and primary myelotibrosis: recommendations from an ad hoc international expert panel [J].

Tefferi, Ayalew ;

Thiele, Juergen ;

Orazi, Attilio ;

Kvasnicka, Hans Michael ;

Barbui, Tiziano ;

Hanson, Curtis A. ;

Barosi, Giovanni ;

Verstovsek, Srdan ;

Birgegard, Gunnar ;

Mesa, Ruben ;

Reilly, John T. ;

Gisslinger, Heinz ;

Vannucchi, Alessandro M. ;

Cervantes, Francisco ;

Finazzi, Guido ;

Hoffman, Ronald ;

Gilliland, D. Gary ;

Bloomfield, Clara D. ;

Vardiman, James W. .

BLOOD, 2007, 110 (04) :1092-1097

← 1 →